Psychotherapy and Psychosomatics

 

Psychometric Properties of a Scale to Measure Alexithymia

Blanchard E.B. · Arena J.G. · Pallmeyer T.P.

Author affiliations

State University of New York at Albany, Albany, N.Y., USA

Related Articles for ""

Psychother Psychosom 1981;35:64–71

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: February 16, 2010
Issue release date: 1981

Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 0

ISSN: 0033-3190 (Print)
eISSN: 1423-0348 (Online)

For additional information: https://www.karger.com/PPS

Abstract

Four studies were conducted on a sample of 230 undergraduates to determine the psychometric properties of a measure of alexithymia, the Schalling-Sifheos Scale. In the first study it was found that scores on the scale are approximately normally distributed for each sex with 8.2% of males and 1.8% of females in the alexithymia range. In the second study a factor analysis of the scale revealed three distinct factors: (1) ‘difficulty in expression of feelings’; (2) ‘the importance of feelings especially about people’; (3) ‘daydreaming or introspection’. In the second factor analytic study, scores from several standard psychological tests on the same subjects were introduced with the scale items. Two factors in this analysis were comprised almost entirely of the other test scores: a ‘general psychological distress factor’ and a ‘concerns about physical symptoms factor’. The other two factors were similar to factors 1 and 2 above in terms of items. The Rathus Assertiveness Scale loaded positively on the equivalent of factor 1. In the last study, it was shown that the Schalling-Sifheos Scale score is relatively orthogonal to other psychological tests with the exception of a Psychosomatic Symptom Checklist and thus is measuring something other than depression, anxiety, etc.

© 1981 S. Karger AG, Basel




Related Articles:


Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: February 16, 2010
Issue release date: 1981

Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 0

ISSN: 0033-3190 (Print)
eISSN: 1423-0348 (Online)

For additional information: https://www.karger.com/PPS


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP